Lecia Sequist
Overview
Explore the profile of Lecia Sequist including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
906
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Leighl N, Ismaila N, Durm G, Florez N, Freeman-Daily J, Pellini B, et al.
J Clin Oncol
. 2025 Feb;
:JCO2402786.
PMID: 40014838
.
2.
Jaiyesimi I, Leighl N, Ismaila N, Alluri K, Florez N, Gadgeel S, et al.
J Clin Oncol
. 2024 Feb;
42(11):e23-e43.
PMID: 38417098
Purpose: To provide evidence-based recommendations for patients with stage IV non-small cell lung cancer (NSCLC) without driver alterations. Methods: This ASCO living guideline offers continually updated recommendations based on an...
3.
Jaiyesimi I, Leighl N, Ismaila N, Alluri K, Florez N, Gadgeel S, et al.
J Clin Oncol
. 2024 Feb;
42(11):e1-e22.
PMID: 38417091
Purpose: To provide evidence-based recommendations for patients with stage IV non-small cell lung cancer with driver alterations. Methods: This ASCO living guideline offers continually updated recommendations based on an ongoing...
4.
Owen D, Singh N, Ismaila N, Blanchard E, Celano P, Florez N, et al.
J Clin Oncol
. 2022 Dec;
41(5):e10-e20.
PMID: 36534938
.
5.
Owen D, Singh N, Ismaila N, Blanchard E, Celano P, Florez N, et al.
J Clin Oncol
. 2022 Dec;
41(5):e1-e9.
PMID: 36534935
.
6.
Rolfo C, Mack P, Scagliotti G, Aggarwal C, Arcila M, Barlesi F, et al.
J Thorac Oncol
. 2021 Jul;
16(10):1647-1662.
PMID: 34246791
Although precision medicine has had a mixed impact on the clinical management of patients with advanced-stage cancer overall, for NSCLC, and more specifically for lung adenocarcinoma, the advances have been...
7.
Sands J, Tammemagi M, Couraud S, Baldwin D, Borondy-Kitts A, Yankelevitz D, et al.
J Thorac Oncol
. 2020 Nov;
16(1):37-53.
PMID: 33188913
Lung cancer is the leading cause of cancer-related deaths worldwide, accounting for almost a fifth of all cancer-related deaths. Annual computed tomographic lung cancer screening (CTLS) detects lung cancer at...
8.
Lee C, Lord S, Marschner I, Wu Y, Sequist L, Rosell R, et al.
J Thorac Oncol
. 2018 Mar;
13(6):792-800.
PMID: 29580950
Introduction: Traditionally, marked tumor shrinkage has been assumed to portend better outcome. We investigated whether depth of tumor response was associated with improved survival outcomes in advanced EGFR-mutant NCLC. Methods:...
9.
Izar B, Sequist L, Lee M, Muzikansky A, Heist R, Iafrate J, et al.
Ann Thorac Surg
. 2013 Aug;
96(3):962-8.
PMID: 23932319
Background: Mutations of the epidermal growth factor hormone receptor (EGFR) gene have been associated with improved treatment response and prognosis in advanced non-small lung cancer (NSCLC). However, their prognostic role...
10.
Pirl W, Traeger L, Greer J, Jackson V, Lennes I, Gallagher E, et al.
Palliat Support Care
. 2013 Feb;
11(3):223-9.
PMID: 23399428
Objective: Although depression appears to be associated with worse survival from cancer, the underlying mechanisms of this association are unknown. Tumor epidermal growth factor receptor (EGFR) genotype is a known...